Operating Lease, Right-of-Use Asset of LAVA Therapeutics NV from 31 Dec 2023 to 31 Mar 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: LAVA Therapeutics NV quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2023 to 31 Mar 2025.
LAVA Therapeutics NV Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2025 was $353,000.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

LAVA Therapeutics NV Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$353,000			31 Mar 2025	10-Q	14 May 2025	2025	Q1
Q4 2024	$441,000	-$414,000	-48%	31 Dec 2024	10-Q	06 Nov 2025	2025	Q3
Q4 2023	$855,000			31 Dec 2023	10-K	28 Mar 2025	2024	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.